Persistent Systems stock sees a dip despite positive analyst outlook. The company is on track to meet its revenue guidance of $2 billion by FY27. Strong order bookings and improving profitability are key drivers. Healthcare segment shows renewed growth. Operating margins faced a temporary hit due to labour code changes. Analysts remain optimistic about future performance.
Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%
Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812